BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1371426)

  • 1. Potential for targeting head and neck squamous cell carcinoma with monoclonal antibody K984.
    Schrijvers AH; Gerretsen M; van Walsum M; Braakhuis BJ; Quak JJ; Snow GB; van Dongen GA
    Cancer Immunol Immunother; 1992; 34(4):252-8. PubMed ID: 1371426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and characterization of two differentiation antigens in human stratified squamous epithelia and carcinomas.
    Quak JJ; Schrijvers HG; Brakkee JG; Davis HD; Scheper RJ; Meijer CJ; Snow GB; Van Dongen GA
    Int J Cancer; 1992 Feb; 50(4):507-13. PubMed ID: 1537614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck.
    Schrijvers AH; Quak JJ; Uyterlinde AM; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
    Cancer Res; 1993 Sep; 53(18):4383-90. PubMed ID: 8364934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior localisation and imaging of radiolabelled monoclonal antibody E48 F(ab')2 fragment in xenografts of human squamous cell carcinoma of the head and neck and of the vulva as compared to monoclonal antibody E48 IgG.
    Gerretsen M; Quak JJ; Suh JS; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
    Br J Cancer; 1991 Jan; 63(1):37-44. PubMed ID: 1989663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
    Gerretsen M; Schrijvers AH; van Walsum M; Braakhuis BJ; Quak JJ; Meijer CJ; Snow GB; van Dongen GA
    Br J Cancer; 1992 Sep; 66(3):496-502. PubMed ID: 1520586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization and imaging of radiolabelled monoclonal antibody against squamous-cell carcinoma of the head and neck in tumor-bearing nude mice.
    Quak JJ; Balm AJ; Brakkee JG; Scheper RJ; Haisma HJ; Braakhuis BJ; Meijer CJ; Snow GB
    Int J Cancer; 1989 Sep; 44(3):534-8. PubMed ID: 2777416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a role of the monoclonal antibody E48 defined antigen in cell-cell adhesion in squamous epithelia and head and neck squamous cell carcinoma.
    Schrijvers AH; Gerretsen M; Fritz JM; van Walsum M; Quak JJ; Snow GB; van Dongen GA
    Exp Cell Res; 1991 Oct; 196(2):264-9. PubMed ID: 1893937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and biodistribution of 99mTechnetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patients.
    Stroomer JW; Roos JC; Sproll M; Quak JJ; Heider KH; Wilhelm BJ; Castelijns JA; Meyer R; Kwakkelstein MO; Snow GB; Adolf GR; van Dongen GA
    Clin Cancer Res; 2000 Aug; 6(8):3046-55. PubMed ID: 10955783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid elimination of mouse/human chimeric monoclonal antibodies in nude mice.
    van Gog FB; Brakenhoff RH; Snow GB; van Dongen GA
    Cancer Immunol Immunother; 1997 Apr; 44(2):103-11. PubMed ID: 9177472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting CD44v6 expressed in head and neck squamous cell carcinoma: preclinical characterization of an 111In-labeled monoclonal antibody.
    Sandström K; Nestor M; Ekberg T; Engström M; Anniko M; Lundqvist H
    Tumour Biol; 2008; 29(3):137-44. PubMed ID: 18612218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody (G10) to a common antigen of human squamous cell carcinoma: binding of the antibody to the H type 2 blood group determinant.
    Kimmel KA; Carey TE; Judd WJ; McClatchey KD
    J Natl Cancer Inst; 1986 Jan; 76(1):9-19. PubMed ID: 2416979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysyl oxidase like-4 monoclonal antibody demonstrates therapeutic effect against head and neck squamous cell carcinoma cells and xenografts.
    Görögh T; Quabius ES; Heidebrecht H; Nagy A; Muffels T; Haag J; Ambrosch P; Hoffmann M
    Int J Cancer; 2016 May; 138(10):2529-38. PubMed ID: 26756583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunodiagnosis of human-derived squamous cell carcinoma.
    Wahl RL; Kimmel KA; Beierwaltes WH; Carey TE
    Hybridoma; 1987 Apr; 6(2):111-9. PubMed ID: 3570303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel CD44v6 targeting antibody fragment with improved tumor-to-blood ratio.
    Sandström K; Haylock AK; Spiegelberg D; Qvarnström F; Wester K; Nestor M
    Int J Oncol; 2012 May; 40(5):1525-32. PubMed ID: 22307465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel monoclonal antibody, 3H-1, reactive with squamoproliferative lesions and squamous-cell cancers.
    Parsons PG; Leonard JH; Kearsley JH; Takahashi H; Lin-Jian X; Moss DJ
    Int J Cancer; 1991 Apr; 47(6):847-52. PubMed ID: 1707035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice.
    Folli S; Westermann P; Braichotte D; Pèlegrin A; Wagnières G; van den Bergh H; Mach JP
    Cancer Res; 1994 May; 54(10):2643-9. PubMed ID: 8168092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of aluminium (III) phthalocyanine tetrasulfonate- and meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for their efficacy in photodynamic therapy in vitro.
    Vrouenraets MB; Visser GW; Stigter M; Oppelaar H; Snow GB; van Dongen GA
    Int J Cancer; 2002 Apr; 98(5):793-8. PubMed ID: 11920653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer.
    de Bree R; Roos JC; Quak JJ; den Hollander W; Snow GB; van Dongen GA
    Clin Cancer Res; 1995 Jun; 1(6):591-8. PubMed ID: 9816020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoma-associated monoclonal antibodies in head and neck carcinoma. Immunohistochemistry and biodistribution of monoclonal antibodies 175F4 and 175F11.
    Balm AJ; Hageman PC; Mulder CL; Hilkens J
    Eur Arch Otorhinolaryngol; 1992; 249(5):237-42. PubMed ID: 1524802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a high-affinity monoclonal antibody specific for CD44v6 as candidate for immunotherapy of squamous cell carcinomas.
    Heider KH; Sproll M; Susani S; Patzelt E; Beaumier P; Ostermann E; Ahorn H; Adolf GR
    Cancer Immunol Immunother; 1996 Dec; 43(4):245-53. PubMed ID: 9003471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.